{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:21:40Z","timestamp":1791663700075,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000451"],"award-info":[{"award-number":["32000451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001497"],"award-info":[{"award-number":["82001497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"345 Talent Project of Shengjing Hospital","award":["M0948"],"award-info":[{"award-number":["M0948"]}]},{"name":"345 Talent Project of Shengjing Hospital","award":["M0935"],"award-info":[{"award-number":["M0935"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kallmann syndrome (KS) is a common type of idiopathic hypogonadotropic hypogonadism. To date, more than 30 genes including <jats:italic>ANOS1<\/jats:italic> and <jats:italic>FGFR1<\/jats:italic> have been identified in different genetic models of KS without affirmatory genotype\u2013phenotype correlation, and novel mutations have been found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 35 unrelated patients with clinical features of disorder of sex development were recruited. Custom-panel sequencing or whole-exome sequencing was performed to detect the pathogenic mutations. Sanger sequencing was performed to verify single-nucleotide variants. Copy number variation-sequencing (CNV-seq) was performed to determine CNVs. The pathogenicity of the identified variant was predicted in silico. mRNA transcript analysis and minigene reporter assay were performed to test the effect of the mutation on splicing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>ANOS1<\/jats:italic> gene c.709\u00a0T\u2009&gt;\u2009A and c.711\u00a0G\u2009&gt;\u2009T were evaluated as pathogenic by several commonly used software, and c.1063-2\u00a0A\u2009&gt;\u2009T was verified by transcriptional splicing assay. The c.1063-2\u00a0A\u2009&gt;\u2009T mutation activated a cryptic splice acceptor site downstream of the original splice acceptor site and resulted in an aberrant splicing of the 24-basepair at the 5\u2032 end of exon 8, yielding a new transcript with c.1063\u20131086 deletion. <jats:italic>FRFR1<\/jats:italic> gene c.1835delA was assessed as pathogenic according to the ACMG guideline. The CNV of del(8)(p12p11.22)chr8:g.36140000_38460000del was judged as pathogenic according to the ACMG &amp; ClinGen technical standards.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Herein, we identified three novel <jats:italic>ANOS1<\/jats:italic> mutations and two novel <jats:italic>FGFR1<\/jats:italic> variations in Chinese KS families. In silico prediction and functional experiment evaluated the pathogenesis of <jats:italic>ANOS1<\/jats:italic> mutations. <jats:italic>FRFR1<\/jats:italic> c.1835delA mutation and del(8)(p12p11.22)chr8:g.36140000_38460000del were assessed as pathogenic variations. Therefore, our study expands the spectrum of mutations associated with KS and provides diagnostic evidence for patients who carry the same mutation in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-023-01074-w","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T06:04:04Z","timestamp":1677650644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mutation spectrum of Kallmann syndrome: identification of five novel mutations across ANOS1 and FGFR1"],"prefix":"10.1186","volume":"21","author":[{"given":"Guoming","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"1074_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2265.2001.01277.x","volume":"55","author":"R Quinton","year":"2001","unstructured":"Quinton R, Duke VM, Robertson A, Kirk JM, Matfin G, de Zoysa PA, et al. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf). 2001;55:163\u201374. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01277.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1074_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrendo.2015.112","volume":"11","author":"U Boehm","year":"2015","unstructured":"Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod\u00e9 C, Dunkel L, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547\u201364. https:\/\/doi.org\/10.1038\/nrendo.2015.112.","journal-title":"Nat Rev Endocrinol"},{"key":"1074_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1172-6-41","volume":"6","author":"EM Laitinen","year":"2011","unstructured":"Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, et al. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis. 2011;6:41. https:\/\/doi.org\/10.1186\/1750-1172-6-41.","journal-title":"Orphanet J Rare Dis"},{"key":"1074_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.metabol.2017.10.012","volume":"86","author":"MI Stamou","year":"2018","unstructured":"Stamou MI, Georgopoulos NA. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metabolism. 2018;86:124\u201334. https:\/\/doi.org\/10.1016\/j.metabol.2017.10.012.","journal-title":"Metabolism"},{"key":"1074_CR5","doi-asserted-by":"publisher","unstructured":"Jiang X, Li D, Gao Y, Zhang X, Wang X, Yang Y, et al. A novel splice site variant in ANOS1 gene leads to Kallmann syndrome in three siblings. Gene. 2020;726:144177. https:\/\/doi.org\/10.1016\/j.gene.2019.144177.","DOI":"10.1016\/j.gene.2019.144177"},{"key":"1074_CR6","doi-asserted-by":"publisher","unstructured":"Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, et al. A gene deleted in Kallmann\u2019s syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature. 1991;353:529\u201336. https:\/\/doi.org\/10.1038\/353529a0.","DOI":"10.1038\/353529a0"},{"key":"1074_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/ng1292-305","volume":"2","author":"I del Castillo","year":"1992","unstructured":"del Castillo I, Cohen-Salmon M, Blanchard S, Lutfalla G, Petit C. Structure of the X-linked Kallmann syndrome gene and its homologous pseudogene on the Y chromosome. Nat Genet. 1992;2:305\u201310. https:\/\/doi.org\/10.1038\/ng1292-305.","journal-title":"Nat Genet"},{"key":"1074_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/EJE-17-0335","volume":"177","author":"M Nie","year":"2017","unstructured":"Nie M, Xu H, Chen R, Mao J, Wang X, Xiong S, et al. Analysis of genetic and clinical characteristics of a Chinese Kallmann syndrome cohort with ANOS1 mutations. Eur J Endocrinol. 2017;177:389\u201398. https:\/\/doi.org\/10.1530\/EJE-17-0335.","journal-title":"Eur J Endocrinol"},{"key":"1074_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ng1122","volume":"33","author":"C Dod\u00e9","year":"2003","unstructured":"Dod\u00e9 C, Levilliers J, Dupont JM, De Paepe A, Le D\u00fb N, Soussi-Yanicostas N, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33:463\u20135. https:\/\/doi.org\/10.1038\/ng1122.","journal-title":"Nat Genet"},{"key":"1074_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1210\/er.2003-0040","volume":"26","author":"RT B\u00f6ttcher","year":"2005","unstructured":"B\u00f6ttcher RT, Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev. 2005;26:63\u201377. https:\/\/doi.org\/10.1210\/er.2003-0040.","journal-title":"Endocr Rev"},{"key":"1074_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12958-020-0568-6","volume":"18","author":"A Gach","year":"2020","unstructured":"Gach A, Pinkier I, Szarras-Czapnik M, Sakowicz A, Jakubowski L. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes. Reprod Biol Endocrinol. 2020;18:8. https:\/\/doi.org\/10.1186\/s12958-020-0568-6.","journal-title":"Reprod Biol Endocrinol"},{"key":"1074_CR12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/humu.24246","volume":"42","author":"R Zhang","year":"2021","unstructured":"Zhang R, Chen Z, Song Q, Wang S, Liu Z, Zhao X, et al. Identification of seven exonic variants in the SLC4A1, ATP6V1B1, and ATP6V0A4 genes that alter RNA splicing by minigene assay. Hum Mutat. 2021;42:1153\u201364. https:\/\/doi.org\/10.1002\/humu.24246.","journal-title":"Hum Mutat"},{"key":"1074_CR13","doi-asserted-by":"publisher","unstructured":"Okonechnikov K, Golosova O, Fursov M; UGENE team. Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics. 2012;28:1166\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/bts091.","DOI":"10.1093\/bioinformatics\/bts091"},{"key":"1074_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2009.177","volume":"5","author":"SD Bianco","year":"2009","unstructured":"Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009;5:569\u201376. https:\/\/doi.org\/10.1038\/nrendo.2009.177.","journal-title":"Nat Rev Endocrinol"},{"key":"1074_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13023-015-0287-9","volume":"10","author":"J Sarfati","year":"2015","unstructured":"Sarfati J, Bouvattier C, Bry-Gauillard H, Cartes A, Bouligand J, Young J. Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life. Orphanet J Rare Dis. 2015;10:71. https:\/\/doi.org\/10.1186\/s13023-015-0287-9.","journal-title":"Orphanet J Rare Dis"},{"key":"1074_CR16","doi-asserted-by":"publisher","unstructured":"Chen K, Wang H, Lai Y. Kallmann Syndrome Due to Heterozygous Mutation in SOX10 Coexisting With Waardenburg Syndrome Type II: Case Report and Review of Literature. Front Endocrinol (Lausanne). 2021;11:592831. https:\/\/doi.org\/10.3389\/fendo.2020.592831.","DOI":"10.3389\/fendo.2020.592831"},{"key":"1074_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.6061\/clinics\/2013(sup01)06","volume":"68","author":"AJ Hamada","year":"2013","unstructured":"Hamada AJ, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics (Sao Paulo). 2013;68:39\u201360. https:\/\/doi.org\/10.6061\/clinics\/2013(sup01)06.","journal-title":"Clinics (Sao Paulo)"},{"key":"1074_CR18","doi-asserted-by":"publisher","unstructured":"Cariboni A, Pimpinelli F, Colamarino S, Zaninetti R, Piccolella M, Rumio C, et al. The product of X-linked Kallmann\u2019s syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet. 2004;13:2781\u201391. https:\/\/doi.org\/10.1093\/hmg\/ddh309.","DOI":"10.1093\/hmg\/ddh309"},{"key":"1074_CR19","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1242\/jcs.111.19.2953","volume":"111","author":"N Soussi-Yanicostas","year":"1998","unstructured":"Soussi-Yanicostas N, Faivre-Sarrailh C, Hardelin JP, Levilliers J, Rougon G, Petit C. Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci. 1998;111:2953\u201365.","journal-title":"J Cell Sci"},{"key":"1074_CR20","doi-asserted-by":"publisher","unstructured":"Saadah OI, Banaganapalli B, Kamal NM, Sahly AN, Alsufyani HA, Mohammed A, et al. Identification of a Rare Exon 19 Skipping Mutation in ALMS1 Gene in Alstr\u00f6m Syndrome Patients From Two Unrelated Saudi Families. Front Pediatr. 2021;9:652011. https:\/\/doi.org\/10.3389\/fped.2021.652011.","DOI":"10.3389\/fped.2021.652011"},{"key":"1074_CR21","doi-asserted-by":"publisher","unstructured":"Thongnoppakhun A, Rungroj N, Wilairat P, Vareesangthip K, Sirinavin C, Yenchitsomanus PT. A novel splice-acceptor site mutation (IVS13-2A>T) of polycystic kidney disease 1 (PKD1) gene resulting in an RNA processing defect with a 74-nucleotide deletion in exon 14 of the mRNA transcript. Hum Mutat. 2000;15:115. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(200001)15:1%3c115::AID-HUMU22%3e3.0.CO;2-Z.","DOI":"10.1002\/(SICI)1098-1004(200001)15:1%3c115::AID-HUMU22%3e3.0.CO;2-Z"},{"key":"1074_CR22","doi-asserted-by":"publisher","unstructured":"Cong Y, Wu J, Wang H, Wu K, Huang C, Yang X. Identification of a Hemizygous Novel Splicing Variant in ATRX Gene: A Case Report and Literature Review. Front Pediatr. 2022;10:834087. https:\/\/doi.org\/10.3389\/fped.2022.834087.","DOI":"10.3389\/fped.2022.834087"},{"key":"1074_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/pedi.12612","volume":"19","author":"JL Hwang","year":"2018","unstructured":"Hwang JL, Park SY, Ye H, Sanyoura M, Pastore AN, Carmody D, et al. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy. X-linked syndrome Pediatr Diabetes. 2018;19:388\u201392. https:\/\/doi.org\/10.1111\/pedi.12612.","journal-title":"X-linked syndrome Pediatr Diabetes"},{"key":"1074_CR24","doi-asserted-by":"publisher","first-page":"12621","DOI":"10.1074\/jbc.M117.790097","volume":"292","author":"AP Willems","year":"2017","unstructured":"Willems AP, Gundogdu M, Kempers MJE, Giltay JC, Pfundt R, Elferink M, et al. Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability. J Biol Chem. 2017;292:12621\u201331. https:\/\/doi.org\/10.1074\/jbc.M117.790097.","journal-title":"J Biol Chem"},{"key":"1074_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/cells9020458","volume":"9","author":"K Frey","year":"2020","unstructured":"Frey K, Pucker B. Animal, Fungi, and Plant Genome Sequences Harbor Different Non-Canonical Splice Sites. Cells. 2020;9:458. https:\/\/doi.org\/10.3390\/cells9020458.","journal-title":"Cells"},{"key":"1074_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41436-020-01040-6","volume":"23","author":"DL Polla","year":"2021","unstructured":"Polla DL, Bhoj EJ, Verheij JBGM, Wassink-Ruiter JSK, Reis A, Deshpande C, et al. De novo variants in MED12 cause X-linked syndromic neurodevelopmental disorders in 18 females. Genet Med. 2021;23:645\u201352. https:\/\/doi.org\/10.1038\/s41436-020-01040-6.","journal-title":"Genet Med"},{"key":"1074_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00427-006-0125-0","volume":"217","author":"B Ayari","year":"2007","unstructured":"Ayari B, Soussi-Yanicostas N. FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs. Dev Genes Evol. 2007;217:169\u201375. https:\/\/doi.org\/10.1007\/s00427-006-0125-0.","journal-title":"Dev Genes Evol"},{"key":"1074_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2174\/0929866523666160517123331","volume":"23","author":"V Murcia-Belmonte","year":"2016","unstructured":"Murcia-Belmonte V, Astillero-L\u00f3pez V, Esteban PF. Anosmin 1 Interacts with the Prokineticin Receptor 2 In Vitro Indicating a Molecular Link Between Both Proteins in the Pathogenesis of Kallmann Syndrome. Protein Pept Lett. 2016;23:650\u20135. https:\/\/doi.org\/10.2174\/0929866523666160517123331.","journal-title":"Protein Pept Lett"},{"key":"1074_CR29","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1471-4159.2010.07024.x","volume":"115","author":"V Murcia-Belmonte","year":"2010","unstructured":"Murcia-Belmonte V, Esteban PF, Garc\u00eda-Gonz\u00e1lez D, De Castro F. Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix. J Neurochem. 2010;115:1256\u201365. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07024.x.","journal-title":"J Neurochem"},{"key":"1074_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-1-4614-8090-7_12","volume":"8","author":"F de Castro","year":"2014","unstructured":"de Castro F, Esteban PF, Bribi\u00e1n A, Murcia-Belmonte V, Garc\u00eda-Gonz\u00e1lez D, Clemente D. The adhesion molecule anosmin-1 in neurology: Kallmann syndrome and beyond. Adv Neurobiol. 2014;8:273\u201392. https:\/\/doi.org\/10.1007\/978-1-4614-8090-7_12.","journal-title":"Adv Neurobiol"},{"key":"1074_CR31","doi-asserted-by":"publisher","unstructured":"Louden ED, Poch A, Kim HG, Ben-Mahmoud A, Kim SH, Layman LC. Genetics of hypogonadotropic Hypogonadism-Human and mouse genes, inheritance, oligogenicity, and genetic counseling. Mol Cell Endocrinol. 2021;534:111334. https:\/\/doi.org\/10.1016\/j.mce.2021.111334.","DOI":"10.1016\/j.mce.2021.111334"},{"key":"1074_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.fertnstert.2006.12.044","volume":"88","author":"NA Georgopoulos","year":"2007","unstructured":"Georgopoulos NA, Koika V, Galli-Tsinopoulou A, Spiliotis BE, Adonakis G, Keramida MK, et al. Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome. Fertil Steril. 2007;88:1311\u20137. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.12.044.","journal-title":"Fertil Steril"},{"key":"1074_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1210\/jc.2003-030476","volume":"89","author":"N Sato","year":"2004","unstructured":"Sato N, Katsumata N, Kagami M, Hasegawa T, Hori N, Kawakita S, et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab. 2004;89:1079\u201388. https:\/\/doi.org\/10.1210\/jc.2003-030476.","journal-title":"J Clin Endocrinol Metab"},{"key":"1074_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/humu.9470","volume":"28","author":"C Dod\u00e9","year":"2007","unstructured":"Dod\u00e9 C, Fouveaut C, Mortier G, Janssens S, Bertherat J, Mahoudeau J, et al. Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis. Hum Mutat. 2007;28:97\u20138. https:\/\/doi.org\/10.1002\/humu.9470.","journal-title":"Hum Mutat"},{"key":"1074_CR35","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1073\/pnas.0600962103","volume":"103","author":"N Pitteloud","year":"2006","unstructured":"Pitteloud N, Acierno JS Jr, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2006;103:6281\u20136. https:\/\/doi.org\/10.1073\/pnas.0600962103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1074_CR36","doi-asserted-by":"publisher","unstructured":"Wang D, Lai P. Global retardation and hereditary spherocytosis associated with a novel deletion of chromosome 8p11.21 encompassing KAT6A and ANK1. Eur J Med Genet. 2020;63:104082. https:\/\/doi.org\/10.1016\/j.ejmg.2020.104082.","DOI":"10.1016\/j.ejmg.2020.104082"},{"key":"1074_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2265.2009.03642.x","volume":"72","author":"EB Trarbach","year":"2010","unstructured":"Trarbach EB, Teles MG, Costa EM, Abreu AP, Garmes HM, Guerra G Jr, et al. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1. Clin Endocrinol (Oxf). 2010;72:371\u20136. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03642.x.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01074-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-023-01074-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01074-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T06:05:20Z","timestamp":1677650720000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-023-01074-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1186\/s12958-023-01074-w","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"25 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Shengjing Hospital of China Medical University (approval no. 2021PS548K), and informed consent was obtained from the families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}